Oral semaglutide helps people with diabetes lose fat and keep muscle
Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
A study looked at 32 people with type 2 diabetes who took oral semaglutide for 6 months. They lost fat, improved blood sugar, and kept their muscle mass. Their liver health and blood pressure also got better.
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Systematic Reviews & Meta-Analyses
Max 100Randomized Controlled Trials
Max 90Cohort Studies
Max 72Case-Control Studies
Max 58Cross-Sectional Studies
Max 44Case Reports & Case Series
Max 30Expert Opinion & Narrative Reviews
Max 539 / 72
Evidence Score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
A study looked at 32 people with type 2 diabetes who took oral semaglutide for 6 months. They lost fat, improved blood sugar, and kept their muscle mass. Their liver health and blood pressure also got better.
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Systematic Reviews & Meta-Analyses
Max 100Randomized Controlled Trials
Max 90Cohort Studies
Max 72Case-Control Studies
Max 58Cross-Sectional Studies
Max 44Case Reports & Case Series
Max 30Expert Opinion & Narrative Reviews
Max 539 / 72
Evidence Score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Publication
Authors
Volpe S, Lisco G, Fanelli M, Racaniello D, Colaianni V, Lavarra V, Triggiani D, Crudele L, Triggiani V, Sabbà C, De Pergola G, Piazzolla G
Related Content
Claims (9)
Peptides marketed for fat loss often lack robust human evidence, relying instead on animal data or short-term biomarkers without long-term clinical validation.
Taking oral semaglutide for 6 months helped lower blood sugar levels in 32 people with type 2 diabetes, reducing their HbA1c by about 9% on average.
Half of the 32 people with type 2 diabetes who took oral semaglutide for 6 months lost at least 5% of their body weight.
After 3 months of taking oral semaglutide, 32 people with type 2 diabetes saw a better balance between muscle mass and belly fat, which improved further by 6 months but wasn't statistically significant.
In a group of 32 people with type 2 diabetes, taking oral semaglutide for 6 months led to a noticeable drop in body fat, with an average loss of about 17.6% of their initial fat mass.